BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5922318)

  • 1. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of disulfiram on catecholamine levels in the brain.
    Goldstein M; Nakajima K
    J Pharmacol Exp Ther; 1967 Jul; 157(1):96-102. PubMed ID: 6029496
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the mechanism of adrenergic action of alpha-methyl-m-tyrosine].
    Gessa GL; Vargiu L; Crabai E
    Boll Soc Ital Biol Sper; 1966 Apr; 42(7):359-61. PubMed ID: 5949373
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of the effects of tranquilizers in animals treated with alpha-methyl-l-tryrosine.
    Menon MK; Dandiya PC; Bapna JS
    J Pharmacol Exp Ther; 1967 Apr; 156(1):63-9. PubMed ID: 6023601
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of prostaglandins on catecholamine metabolism of the central nervous system in rats.
    Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(3):221-4. PubMed ID: 6946681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbaryl on catecholamines in brain regions.
    Ray SK; Haque SJ; Poddar MK
    Indian J Exp Biol; 1984 Mar; 22(3):141-4. PubMed ID: 6440860
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of alpha-methyltyrosine on brain catecholamines and conditioned behavior in guinea pigs.
    Moore KE
    Life Sci; 1966 Jan; 5(1):55-65. PubMed ID: 5933656
    [No Abstract]   [Full Text] [Related]  

  • 14. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.
    Fuxe K; Corrodi H; Hökfelt T; Lidbrink P; Ungerstedt U
    Med Biol; 1974 Apr; 52(2):121-32. PubMed ID: 4837435
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of monoamine oxidase inhibition on catecholamine synthesis.
    Neff NH; Costa E
    Life Sci; 1966 May; 5(10):951-9. PubMed ID: 5961718
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive avoidance performance correlates with catecholamine turnover in discrete limbic brain regions.
    Kovács GL; Versteeg DH; de Kloet ER; Bohus B
    Life Sci; 1981 Mar; 28(10):1109-16. PubMed ID: 6112649
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 18. Catecholamines, drugs, and behavior: mutual interactions.
    Seiden LS; Campbell AB
    Adv Biochem Psychopharmacol; 1974; 12(0):325-38. PubMed ID: 4418348
    [No Abstract]   [Full Text] [Related]  

  • 19. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.